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During the past 4 decades, heart surgery has evolved to encom-
pass increasingly complex operations in increasingly complex
patients. Today, patients with multiple noncardiac comorbid-
ities, including old age and organ dysfunction, present with
cardiac pathologies requiring multicomponent operations.1-3
Yet, because most studies of risk factors focus on isolated
procedures, a tool to explain, illustrate, and understand risk
and survival is not readily available when patients with
multiple comorbidities (complex patients) present for
multicomponent heart operations (complex operations).
Furthermore, cardiac surgery programs are evaluated on
the basis of subsets of patients undergoing 1-component op-
erations (isolated coronary artery bypass grafting [CABG],
isolated aortic valve surgery [AV], isolated mitral valve
surgery [MV]) or simple 2-component operations
(CABG þ AV, CABG þ MV).1-3 Risk adjustment is
based on factors representing a subset of demographics
and common comorbidities. When facing complex
patients, we as surgeons use the traditional scores
developed for simple operations and extrapolate the
patient’s risk as best we can, guessing at the contribution
of factors not covered by these scores.
Conceptually, it is easy to make a list of factors that con-
tribute to morbidity and mortality after heart surgery. The
weight of each factor can only be studied retrospectively;
we estimate current risk based on these weights. Learning
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The Journal of Thoracic and Carneutralize the weight of a given risk factor.4-7 Regardless
of the sophistication of the statistics, the predictive value
is, therefore, limited (as expressed by its confidence
limits). No coding system is adequately comprehensive
and inclusive, or granular and precise, or stable across
time. Clinical information description and coding are
performed by physicians and coders with different
backgrounds and education. Understanding any risk
estimate therefore requires an understanding of the data,
and the coding and reporting on which they were based.
Factors included and not included, their definitions, the
accuracy and completeness of recorded clinical
observations, and the faithfulness of their abstraction
determine the reliability of the calculations. One solution
is to develop ever-more elaborate multivariable risk scoring
systems. We illustrate such a system in part 1 of this
commentary.
However, it is easy to get lost in the precision of a numeric
estimate of expected mortality. Surgeons need to be able to
explain to patients and families how the cardiac disease,
planned operation, and other factors like physical strength
or frailty, disabilities, and comorbidities add up tovulnerabil-
ity and risk. A simplified approach will improve our
understanding of this complicated interplay, and its constant
change and development. Congenital heart surgeons have de-
veloped theAristotle Complexity score8 and theRiskAdjust-
ment for Congenital Heart Surgery (RACHS)-1 score,9 both
of which take into account operative complexity and expert
opinion. In part 2 of this commentary, we present a simplified
approach similar to these and the Charlson Comorbidity In-
dex to describe patient and surgical complexity.DESCRIPTION
Complexity was evaluated and analyzed in all patients
undergoing cardiac surgery at the Cleveland Clinic from
1967 to 2010. Patients were divided into 2 cohorts: an evo-
lution cohort including 111,390 patients from 1967 to 2007
and a contemporary risk cohort including 10,337 patients
from 2007 to 2010.Patient Complexity
We defined patient complexity by comorbid disease com-
ponents, excluding details related to the cardiac pathology
that determined the operation. Patient comorbidities in this
context included demographics, functional limitation ac-
cording to symptoms and clinical acuity, and general cardiacdiovascular Surgery c Volume 145, Number 5 1159
TABLE 1. Patient characteristics in evolution (1967-2007; n ¼ 111,390) an
Characteristic
Evoluti
n* N
Demography
Age, y 111,390
Age>75 yy 111,390
Male 111,390
BMI, kg$m-2 80,291
BMI>30 kg$m-2 or<18.5 kg$m-2y 80,291
Acuity
Preoperative NYHA class 111,322
I
II
III
IV
Emergency operation 107,141
Patient acuityy,z —
Cardiac comorbidity
Previous or evolving MIy 111,118
Ejection fraction<50%y 51,738
Preoperative AF/flutter 111,390
Preoperative arrhythmiay,x —
Heart failurey 111,390
Previous cardiac operationy 111,390
Noncardiac comorbidity
History of pharmacologically treated diabetesy 103,764
History of PADy 61,675
History of hypertensiony 82,092
History of COPDy 55,865
History of malignancyy 80,774
Renal failurey,jj —
History of renal disease{ 55,699
Dyslipidemiay,** —
Cholesterol, mg/dL 76,968
Bilirubin, mg/dLyy 55,159
Liver dysfunctiony,zz 55,159
Hematocrit, % 48,350
Anemiay,xx 48,350
Previous strokey 111,390
SD, Standard deviation; BMI, body mass index; NYHA, New York Heart Association; MI,
chronic obstructive pulmonary disease. *Number of patients with data available. Because
ularly in response to refinements of the Society of Thoracic Surgeons National Database.
count of patient complexity. zPreoperative intra-aortic balloon pump support, inotrope su
arrhythmia or heart block. jjPreoperative dialysis or creatinine 2.5 mg/dL1. {Documen
insufficiency, or creatinine 2 mg/dL. **Total cholesterol>200 mg/dL, low-density lipo
85th percentiles. zzTotal bilirubin>1.0 mg/dL. xxHematocrit<35%.
Abbreviations and Acronyms
aorta ¼ aortic root, ascending aorta, or arch
replacement
AV ¼ aortic valve surgery
CABG ¼ coronary artery bypass grafting
MV ¼ mitral valve surgery
RACHS ¼ Risk Adjustment for Congenital Heart
Surgery
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of components used for the elaborate approach (part 1) is
presented in Appendix E1, and the comparison of evolution
and contemporary risk cohorts in Table 1. For the simplified
approach (part 2), we used the strategy exemplified by the
Charlson Comorbidity Index,10 with inclusion of comorbid-
ities related to each physiologic system and complexity
defined by count of comorbid disease components.Surgical Complexity
Similar to patient complexity, surgical complexity
was assessed by surgical components. All procedurald contemporary risk (2007-2010; n ¼ 10,337) cohorts
on Cohort Contemporary Risk Cohort
o. (%) or mean ± SD n* No. (%) or mean ± SD
60  12 10,337 63  14
11,678 (10) 10,337 2130 (21)
83,246 (75) 10,337 6804 (66)
27  5.0 10,337 29  8.8
20,338 (25) 10,337 3423 (33)
8908
19,670 (18) 2344 (26)
44,692 (40) 3714 (42)
17,553 (16) 2320 (26)
29,407 (26) 530 (6.0)
3194 (3.0) 10,329 260 (2.5)
— 10,337 1047 (10)
51,900 (47) 10,337 2448 (24)
20,579 (40) 10,337 2788 (27)
8186 (7.3) 9828 1123 (11)
— 10,337 2,939 (28)
26,416 (24) 10,337 2510 (24)
19,296 (17) 10,337 2572 (25)
16,642 (16) 10,337 2497 (24)
25,056 (41) 10,337 812 (7.9)
50,031 (61) 10,337 7221 (70)
10,654 (19) 10,319 1293 (13)
4881 (6.0) 10,337 315 (3.0)
— 10,337 314 (3.0)
3,098 (5.8) — —
— 10,337 7120 (69)
218  57 8616 169  45
0.4, 0.6, 1.1 10,157 0.3, 0.5, 0.9
9188 (17) 10,157 1288 (13)
39  5.5 10,330 40  5.6
9869 (20) 10,330 2119 (20)
6710 (6.0) 10,337 1804 (17)
myocardial infarction; AF, atrial fibrillation; PAD, peripheral arterial disease; COPD,
the database dates back to the early 1970s, variables were added periodically, partic-
Thus, missing data were generally ‘‘block missing.’’ yComorbidities incorporated in
pport, cardiogenic shock, or emergency operation. xPreoperative atrial or ventricular
tation of renal failure, renal artery stenosis, end-stage renal disease, chronic renal
protein 130 mg/dL, or high-density lipoprotein<40 mg/dL. yyFifteenth, 50th, and
gery c May 2013
TABLE 2. Evolution cohort (1967-2007): Mutually exclusive surgical
groups and associated mortality
Surgical groups n
Hospital mortality,
No. (%)
One component
CABG 68,626 1200 (1.7)
Major LV procedure 522 44 (8.4)
AV 6864 182 (2.7)
Septal myectomy 578 6 (1.0)
MV 8728 190 (2.2)
AF 130 0 (0)
TV 212 18 (7.8)
Aorta 445 53 (12)
Heart transplant 1049 57 (5.4)
Pericardectomy 325 16 (4.9)
Resection of cardiac tumor 145 8 (5.5)
Two components
CABG þ CEA 1647 84 (5.1)
CABG þ TMR 153 2 (1.3)
CABG þ ASD/PFO 140 2 (1.4)
Major LV procedure þ CABG 1095 86 (7.8)
Major LV procedure þ MV 68 4 (5.6)
AV þ ASD/PFO 65 0 (0)
AV þ CABG 4843 191 (3.9)
AV þ MV 1795 94 (5.2)
AV þ TV 108 6 (5.6)
Septal myectomy þ AV 84 4 (4.8)
Septal myectomy þ MV 152 5 (3.3)
Septal myectomy þ CABG 175 4 (2.3)
MV þ CABG 3619 219 (6.1)
MV þ TV 1202 60 (5.0)
MV þ ASD/PFO 251 7 (2.8)
AF þ MV 251 2 (0.8)
TV þ CABG 68 6 (8.8)
Aorta þ CABG 327 40 (12.2)
Aorta þ AV 2179 52 (2.4)
Three components
Major LV procedure þ MV þ CABG 164 16 (9.8)
AV þ CABG þ CEA 57 5 (8.8)
AV þ MV þ CABG 917 66 (7.2)
AV þ MV þ TV 412 40 (9.7)
AV þ MV þ TV þ CABG 209 26 (12)
Septal myectomy þ AV þ CABG 55 3 (5.5)
MV þ CABG þ ASD/PFO 124 5 (4.0)
MV þ TV þ ASD/PFO 70 1 (1.4)
MV þ TV þ CABG 461 43 (9.3)
AF þ MV þ CABG 66 1 (1.5)
AF þ MV þ TV 94 2 (2.1)
Aorta þ AV þ CABG 1062 80 (7.5)
Aorta þ AV þ MV 180 16 (8.9)
Aorta þ MV þ CABG 36 8 (22)
(Continued)
TABLE 2. Continued
Surgical groups n
Hospital mortality,
No. (%)
Four components
Aorta þ AV þ MV þ CABG 141 9 (6.4)
Aorta þ AV þ MV þ TV 38 7 (18)
Miscellaneous 1425 76 (5.3)
CABG, Coronary artery bypass grafting; LV, left ventricle; AF, Maze procedure
(including non–cut-and-sew Maze); CEA, carotid endarterectomy; TMR, transmyo-
cardial (laser) revascularization; ASD/PFO, atrial septal defect or patent foramen
ovale closure; MV, mitral valve surgery; AV, aortic valve surgery; TV, tricuspid valve
surgery; Aorta, aortic root, ascending aorta, or arch replacement.
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adults at the Cleveland Clinic from 1967 to 2007 were tab-
ulated. Stand-alone components were those often per-
formed as an isolated operation. Add-on components wereThe Journal of Thoracic and Carthose not commonly performed as an isolated operation. Ig-
nored components were minor portions of an operation and
were not counted.
Eleven components were considered stand-alone:
 CABG
 AV
 MV
 Tricuspid valve surgery (TV)
 Maze procedure, including non–cut-and-sew maze (AF)
 Aortic root, ascending aorta, or arch replacement (aorta)
 Major left ventricular procedure
 Septal myectomy
 Resection of cardiac tumor
 Pericardectomy
 Heart transplant
Three components were considered add-on:
 Carotid endarterectomy
 Transmyocardial (laser) revascularization
 Atrial septal defect or patent foramen ovale closure
Ignored minor components included pacemaker or lead
procedures, myocardial biopsy, coronary reimplantation,
reimplantation of coronary graft, aortoplasty, aortic endar-
terectomy, aortic biopsy, aortic thrombectomy, femoral
artery repair, left atrial appendage amputation or closure,
pericardial procedure other than pericardectomy, minor
ventriculotomy, and cell transplant.
For the elaborate approach, every combination of these
surgical components in the evolution cohort, for which
there were at least 50 patients or 5 events (47 mutually
exclusive surgical groups, isolated or combinations)
was analyzed (Table 2). For the simplified approach, sur-
gical complexity was defined by number of distinct
stand-alone and add-on components comprising a given
operation.
Evolution of Complexity
Patient comorbidity factors such as age, bodymass index,
and proportions of female patients and patients with diabe-
tes mellitus have increased across time, whereas New York
Heart Association functional class has decreased, indicatingdiovascular Surgery c Volume 145, Number 5 1161
FIGURE 1. Evolution of patient complexity. Each circle represents a 1-year average (mean for continuous variables and percentage for categorical vari-
ables). A, Age. B, Female gender. C, Treated diabetes mellitus and body mass index (BMI). D, Patients in New York Heart Association (NYHA) functional
classes III and IV.
Editorial Pettersson et al
E
D
IT
O
R
IA
L
E
D
IT
O
R
IA
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earlier in the course of their heart disease (Table 1 and
Figure 1).
Surgical complexity increased across time, accelerating
since the mid 1990s (Figure 2, A). The proportion of iso-
lated CABG procedures steadily declined across time,
whereas CABG combined with other procedures increased
(Figure 2, B). Thus, the proportion of operations for which
benchmarks have been developed by the Society of Tho-
racic Surgeons and included in Society of Thoracic Sur-
geons scores has declined such that more than half the
operations performed at our institution are now more com-
plex than these, and no benchmarks for risk are available
(Figure 2, C).
In the contemporary risk cohort, 49% of operations per-
formed were 1 component; 33%, 2 component; 13%, 3
component; and 4%, 4 component. Coronary artery by-
pass grafting was performed in 86 different combinations,
including isolated CABG, 13 combinations of CABG þ 1
component, 28 combinations of CABG þ 2 components,
31 combinations of CABG þ 3 components, 11 combina-
tions of CABG þ 4 components, and 2 combinations of
CABG þ 5 components (Box 1). An aortic valve proce-
dure (AV) was performed in 85 different combinations,1162 The Journal of Thoracic and Cardiovascular Surincluding an isolated AV, 10 combinations of AV þ 1
component, 26 combinations of AV þ 2 components, 31
combinations of AV þ 3 components, 15 combinations
of AV þ 4 components, and 2 combinations of AV þ 5
components (Box E1). A mitral valve procedure (MV)
was performed in 83 different combinations, including
an isolated MV, 11 combinations of MV þ 1 component,
25 combinations of MV þ 2 components, 31 combinations
of MV þ 3 components, 13 combinations of MV þ 4
components, and 2 combinations of MV þ 5 components
(Box E2). An aortic procedure was performed in 66 differ-
ent combinations, including an isolated aortic procedure, 9
combinations of aortic procedure þ 1 component, 21 com-
binations of aortic procedure þ 2 components, 22 combi-
nations of aortic procedure þ 3 components, 11
combinations of aortic procedure þ 4 components, and 2
combinations of aortic procedure þ 5 components
(Box E3).
PART 1: ELABORATE MULTIVARIABLE
APPROACH TO RISK ASSESSMENT
Risk factors for hospital mortality were identified and
analyzed separately for patient comorbidity components
and surgical components using logistic regression analysis.gery c May 2013
FIGURE 2. Evolution of surgical complexity. A, Surgical complexity il-
lustrated as percentage of patients undergoing operations with 1 (filled cir-
cles), 2 (open circles), 3 (triangles), or  4 (squares) components.
B, Percentage of patients undergoing isolated coronary artery bypass graft-
ing (CABG) or CABG plus other components (CABGþ). C, Percentage of
patients undergoing procedures for which risk adjustment equations have
been developed by the Society of Thoracic Surgeons (STS) and those
more complex than these (Other).
FIGURE 3. Prevalence of multicomponent operations (2 components,
filled circles) and percent hospital mortality (open circles).
FIGURE 4. Receiver–operator curves for logistic regression analysis of
patient (short-dash line) and surgical complexity (long-dash line).
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from 1967 to 2007. Hospital mortality decreased substan-
tially across time (Figure 3). Patient complexity alone was
a powerful predictor of hospital mortality (C ¼ 0.812;
Figure 4, Table E1). This analysis was used to calculate
a patient complexity score.The Journal of Thoracic and CarNext, the association between hospital mortality and
surgical complexity was assessed by logistic regression
analysis in 3 models: (1) the operation accounted for
by individual surgical components, (2) the operation ac-
counted for by surgical groups as defined in Table 2, and
(3) the operation accounted for by individual surgical com-
ponents combined with statistically significant groups (in-
teractions) (Figure 5).
TheC statistic for the unadjustedmodel containing the in-
dividual surgical components was only 0.647, but it was
0.824 after adjusting for patient complexity score
(Figure 4 and Table E2).When using surgical groups instead
of individual surgical components to calculate the contribu-
tion of the operation to risk, the C statistic for the unadjusted
groupmodel was 0.652 andwas 0.827 after adjusting for pa-
tient complexity score. Certain surgical groups were poorly
accounted for by components alone, as illustrated by outliers
in Figure 5, indicating that important interactions existed.
Aorta procedureswith concomitant CABG, isolated TV, iso-
lated aorta, major left ventricular procedure, and CABGdiovascular Surgery c Volume 145, Number 5 1163
FIGURE 5. Bubble plot of predicted risk of hospital mortality calculated
by isolated surgical components versus surgical groups. Bubbles distant
from line of identity (outliers) represent important interactions. The size
of each bubble represents size of the surgical group, with the largest being
isolated coronary artery bypass grafting.
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risk. In the final model, interactions were accounted for by
combining components and statistically significant groups
to modulate risk, resulting in a C statistic of 0.694, and
0.827 after adjusting for patient complexity score (Table
3). In all 3 models, patient, rather than surgical, complexityTABLE 3. Logistic model for hospital death incorporating surgical
components and interactions
Procedure Estimate ± SE P
Pericardiectomy 1.32  0.22 <.0001
Major LV procedure 1.07  0.11 <.0001
Atrial myxoma 0.93  0.33 .004
Carotid endarterectomy 0.92  0.11 <.0001
Septal myectomy 0.66  0.20 .001
Aorta 0.55  0.088 <.0001
AV 0.36  0.053 <.0001
MV 0.35  0.065 <.0001
CABG 0.33  0.059 <.0001
Maze procedure 0.20  0.17 .2
TV 0.16  0.089 .07
Transplant 0.093  0.16 .6
Transmyocardial revascularization 0.092  0.60 .8
Atrial septal defect or patent foramen
ovale closure
0.15  0.21 .4
Interactions
CABG þ aorta 1.20  0.21 <.0001
Isolated aorta 1.04  0.19 <.0001
Isolated TV 0.88  0.29 .002
Isolated major LV procedure 0.48  0.21 .05
CABG þ MV 0.35  0.11 .0005
Preoperative risk 0.96  0.016 <.0001
Intercept 0.70  0.08 <.0001
C¼ 0.83. SE, Standard error; LV, left ventricle; aorta, aortic root, ascending aorta, or
arch replacement; AV, aortic valve surgery;MV, mitral valve surgery;CABG, coronary
artery bypass grafting; TV, tricuspid valve surgery.
1164 The Journal of Thoracic and Cardiovascular Suraccounted for most of the information predicting hospital
mortality (Figure 4).
The elaborate approach based on multivariable analysis
is of great value for risk-adjusted national reporting of out-
comes and quality improvement efforts. It is patient and risk
factor specific, allowing the best possible direct comparison
of treatment options and program outcomes. Developing
such a score has allowed us to better understand issues re-
lated to risk scoring. Its limitations are its complexity,
which is why only 1- and 2-component operations are cov-
ered by scores based on this approach. Practical implemen-
tation of an elaborate score, including even more granular
data, requires a large data set with many variables solved
automatically from entry into electronic medical records.
It also requires constant updates as we learn and progress
(Figure 6).
PART 2: SIMPLIFIED APPROACH TO
CONTEMPORARY RISK ASSESSMENT
The simplified approach defined patient complexity by
count of comorbid disease components (Table 1) and defined
surgical complexity by count of surgical components. For the
10,337 patients undergoing cardiac operations performed
from 2007 to 2010, 4191 (40%) had  5 comorbidities
(Figure 7). Postoperative mortality and morbidity increased,
and late survival decreased with increasing patient (Table 4
and Figure 8, A) and surgical complexity (Table 5 and
Figure 8, B). As patient complexity increased, the risk of
multicomponent procedures became more evident
(Figure 9). However, even for patients with many comorbid-
ities, complex operationswere performedwith relatively low
risk and acceptable survival. The relationship of surgical
complexity and hospital mortality varied somewhat accord-
ing to type of procedure (Figure 10), with particular variabil-
ity for thoracic aorta procedures. Intermediate-term survival
decreased incrementally as patient and surgical complexity
increased (Figure 11, A and B).
Discussions with patients and families about risk of com-
plex operations are not only about providing percentages,
but also about conveying an understanding of the relation-
ship between patient factors, comorbidities, operative com-
ponents, and outcomes. This is not easy to do, particularly
for the complex patient about to undergo a complex opera-
tion. This is the primary advantage of a simple tool to illus-
trate the interplay of these factors. Patients undergoing
simple operations tended to have few comorbidities;
patients requiring more complex operations always had
several comorbidities (Figure 12).
The list of patient factors related to risk will continue to
evolve. For example, recent discussions about patient frailty
are an indication that we have not captured all deciding fac-
tors.11-14 Included operations and their components were
also limited; we are aware of the possibility of further
dividing these operations and components into subgroups,gery c May 2013
FIGURE 6. Predicted decline in hospital mortality for different patient risk profiles. A, For a fixed preoperative patient risk profile of 0.05, predicted mor-
tality for 1-, 2-, and 4-component operations. B, For a preoperative patient risk profile of 0.30, predicted mortality for 1-, 2-, and 4-component operations.
C, For a range of preoperative patient risk profiles, mortality for a 4-component operation. D, Univariable effect of aortic clamp time for 4 eras.
CABG, Coronary artery bypass grafting; MV, mitral valve surgery; AV, aortic valve surgery; TV, tricuspid valve surgery.
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and technology. Counting operative components suggests
that risk of each component is the same. TraditionalFIGURE 7. Contemporary complexity: Distribution of patient
comorbidities.
The Journal of Thoracic and Carmodels presume that variations in the operating room are
absorbed by patient factors included in the model when, in
fact, the same operation varies according to the pathology
and etiology for which it is performed. Operative and
cardiopulmonary bypass times are likely to influence risk,
as can other factors related to surgeon skill and experience.
Some variables do not fall neatly into patient or surgical
factors because they carry information about both. Among
these is surgical acuity, which reflects not only serious,
possibly life-threatening, patient risk, but also interrup-
tions in the surgical schedule, operations performed off
hours with less experienced personnel, and fatigue. Other
variables that span both categories are cardiac comorbid-
ities, such as extent of coronary disease, endocarditis, pre-
vious cardiac surgery, and atrial fibrillation. These reflect
a patient’s condition, but also influence the surgical ap-
proach, which is tailored to the patient’s anatomy and pa-
thology, and may vary among surgeons. The surgeon may
decide to address or not to address cardiac pathologies
such as moderate valve and coronary lesions, and atrial fi-
brillation. We did not consider the severity of the cardiacdiovascular Surgery c Volume 145, Number 5 1165
TABLE 4. Contemporary risk cohort (2007-2010): Postoperative mortality and morbidity complications by number of patient comorbidities
Complications
Comorbidities
P*
None
(n ¼ 461)
No. (%)
1
(n ¼ 978)
No. (%)
2
(n ¼ 1348)
No. (%)
3-4
(n ¼ 3086)
No. (%)
5-6
(n ¼ 2451)
No. (%)
7-8
(n ¼ 1404)
No. (%)
9
(n ¼ 609)
No. (%)
Mortality
In-hospital 0 (0) 3 (0.31) 1 (0.07) 50 (1.6) 79 (3.2) 60 (4.3) 75 (12) <.0001
In-hospital or within 30-d 1 (0.22) 4 (0.41) 3 (0.22) 58 (1.9) 94 (3.8) 76 (5.4) 80 (13) <.0001
6-Month survival,% 99.8 99.1 98.3 96.7 92.6 88 75 <.0001
12-Month survival,% 99.3 98.4 97.5 95.7 90.3 83 70
Morbidity
STS compositey 41 (8.9) 87 (8.9) 158 (12) 568 (18) 731 (30) 586 (42) 335 (55) <.0001
Renal failure 4 (0.88) 7 (0.72) 15 (1.1) 128 (4.2) 191 (8.0) 168 (12) 106 (18) <.0001
Stroke 7 (1.5) 6 (0.62) 25 (1.9) 44 (1.5) 48 (2.0) 32 (2.4) 19 (3.3) .002
Reoperation for bleeding 21 (4.6) 40 (4.1) 44 (3.3) 119 (3.9) 151 (6.3) 96 (7.1) 67 (12) <.0001
Prolonged ventilation (>24 h) 10 (2.2) 42 (4.3) 98 (7.3) 417 (14) 587 (25) 466 (34) 294 (51) <.0001
Length of stay, 15th, 50th, and 85th percentiles
ICU, hours 21, 25, 48 21, 26, 53 22, 27, 73 22, 32, 97 24, 52, 160 27, 84, 238 44, 106, 477 <.0001
Postoperative, days 4, 5, 7 4, 5, 8 4, 6, 9 5, 7, 11 5, 8, 16 6, 11, 21 7, 13, 29 <.0001
STS, Society of Thoracic Surgeons; ICU, intensive care unit. *Test for trend. yComposite event for any of the following STS complications: renal failure, stroke, prolonged ven-
tilation, reoperation for bleeding, graft occlusion, valve dysfunction, or other cardiac reoperation.
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completeness of the operations. We did not study benefits
of surgery relative to other treatment options; however,
multiple publications from this institution have demon-
strated increasing relative benefit as patients become
sicker and higher risk.6,15
CONCLUSIONS
The traditional, elaborate multivariable approach to risk
scores has an important place, but even with large national
databases and ever richer variables, these scores do not yet
apply to complex patients with complex heart disease. TheTABLE 5. Contemporary risk cohort (2007-2010): Postoperative mortalit
Complications
1
(n ¼ 5107)
No. (%)
(n ¼
No.
Mortality
In-hospital 102 (2.0) 78
In-hospital or 30-d 119 (2.3) 95
6-Month survival,% 95.4 9
12-Month survival,% 93.8 9
Morbidity
STS compositey 1008 (20) 854
Renal failure 241 (4.9) 215
Stroke 77 (1.6) 66
Reoperation for bleeding 200 (4.0) 198
Prolonged ventilation (>24 h) 728 (15) 655
Length of stay, 15th, 50th, and 85th percentiles
ICU, hours 22, 30, 105 23, 4
Postoperative, days 4, 6, 12 5, 7
STS, Society of Thoracic Surgeons; ICU, intensive care unit. *Test for trend. yComposite e
tilation, reoperation for bleeding, graft occlusion, valve dysfunction, or other cardiac reop
1166 The Journal of Thoracic and Cardiovascular Surneed for a scoring system to benchmark outcomes of com-
plex procedures is obvious. Benchmarking only the sim-
plest procedures does not give credit to institutions
making great efforts to care for complex patients requiring
complex operations. When facing these patients, we as sur-
geons use traditional scores developed for simple opera-
tions and extrapolate the patient’s risk as best we can,
guessing at the contribution of factors not covered by these
scores. The approach congenital heart surgeons have taken
with the Aristotle and RACHS scores is also a compromise;
these scores use patient data to calibrate expert opinion
about the complexity of the operation.y and morbidity complications by number of surgical components
Surgical components
P*
2
3467)
(%)
3
(n ¼ 1335)
No. (%)
4
(n ¼ 366)
No. (%)
5
(n ¼ 62)
No. (%)
(2.3) 53 (4.0) 30 (8.2) 5 (8.1) <.0001
(2.7) 61 (4.6) 34 (9.3) 7 (11) <.0001
4.0 91 83 71 <.0001
2.2 89 79 68
(25) 457 (34) 153 (42) 34 (55) <.0001
(6.3) 105 (7.9) 45 (12) 13 (21) <.0001
(1.9) 29 (2.2) 9 (2.5) 0 (0) .11
(5.8) 103 (7.8) 31 (8.6) 6 (9.7) <.0001
(19) 375 (28) 131 (36) 25 (41) <.0001
5, 140 25, 67, 182 27, 85, 333 40, 106, 509 <.0001
, 14 6, 9, 18 7, 11, 23 7, 13, 29 <.0001
vent for any of the following STS complications: renal failure, stroke, prolonged ven-
eration.
gery c May 2013
FIGURE 8. Contemporary complexity and hospital mortality. A, Hospital mortality according to number of comorbidities (patient complexity). B, Hos-
pital mortality according to number of surgical components (surgical complexity).
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LRisk is better understood in the context of evolving pa-
tient and procedure complexity than by a single numeric es-
timate of expected mortality. The interplay of patient and
surgical complexity with outcomes and survival after heart
operations is best understood by combining conventional
elaborate multivariable analysis and a simple approach
based on counts of comorbidities and required surgical
components. Risk of postoperative mortality and morbidity
increases and survival worsens with patient and surgical
complexity, with patient complexity being most important.
There is a strong correlation between mortality (hospital
and 30-day), morbidity, and 6- and 12-month survival.
Today, however, few operations are hopeless. A simpli-
fied approach to risk assessment improves our understand-
ing of complexity and outcomes, and facilitates discussions
with patients and families.References
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FIGURE 10. Hospital mortality according to number of surgical components for operations including (A) coronary artery bypass grafting (CABG), (B)
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FIGURE 11. Survival after cardiac operations. Symbols at yearly inter-
vals are Kaplan-Meier estimates accompanied by vertical bars representing
asymmetric confidence limits equivalent to 1 standard error. Solid lines
within dashed confidence bands represent parametric estimates. A, Unad-
justed mortality stratified by the number of patient comorbidities (0-1, 2,
3-4, 5-6, 7-8, or9; because of the small number of events in the 0-1 group,
there are no parametric estimates). B, Unadjusted mortality stratified by the
number of surgical components (1, 2, 3, 4, or 5).
BOX 1. Coronary artery bypass grafting combinations with 5 or more
operations performed
Isolated CABG
CABG + 1 component
+ AV
+ MV
+ TV
+ AF
+ Aorta
+ Major LV procedure
+ Septal myectomy
+ Resection of atrial myxoma or tumor
+ Pericardiectomy
+ Heart transplant
+ Carotid endarterectomy
+ Transmyocardial (laser) revascularization
+ ASD/PFO
CABG + 2 components
+ Aorta + AV
+ Aorta + MV
+ AV + AF
+ AV + MV
+ MV + AF
+ MV + ASD/PFO
+ MV + TV
+ Major LV procedure + MV
+ Septal myectomy + AV
CABG + 3 components
+ Aorta + AV + MV
+ Aorta + AV + AF
+ AV + MV + AF
+ AV + MV + TV
+ MV + TV + AF
CABG + 4 components
+ Aorta + AV + MV + TV
+ Aorta + AV + MV + AF
+ AV + MV + TV + AF
CABG, Coronary artery bypass grafting; AV, aortic valve surgery; MV, mitral valve
surgery; TV, tricuspid valve surgery; AF, maze procedure (including non–cut-and-
sew maze); aorta, aortic root, ascending aorta, or arch replacement; LV, left ventric-
ular; ASD/PFO, atrial septal defect or patent foramen ovale closure.
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demonstrated by number of comorbidities) undergoing 1-, 2-, 3-, 4-, or5-
component operations.
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BOX E1. Aortic valve combinations with 5 operations performed
Isolated AV
AV + 1 component
+ Aorta
+ CABG
+ AF
+ ASD/PFO
+ MV
+ TV
+ Septal myectomy
AV + 2 components
+ Aorta + CABG
+ Aorta + MV
+ Aorta + AF
+ Aorta + ASD/PFO
+ Aorta + TV
+ CABG + AF
+ CABG + CEA
+ MV + AF
+ MV + CABG
+ MV + TV
+ TV + AF
+ Septal myectomy + CABG
+ Septal myectomy + MV
AV + 3 components
+ Aorta + MV + CABG
+ Aorta + MV + TV
+ Aorta + MV + AF
+ MV + CABG + AF
+ MV + TV + AF
+ MV + TV + CABG
AV + 4 components
+ Aorta + CABG + MV + TV
+ Aorta + CABG + MV + AF
+ CABG + MV + TV + AF
AV, Aortic valve surgery; aorta, aortic root, ascending aorta, or arch replacement;
CABG, coronary artery bypass grafting; AF, maze procedure (including non–cut-
and-sew maze); ASD/PFO, atrial septal defect or patent foramen ovale closure;
MV, mitral valve surgery; TV, tricuspid valve surgery; CEA, carotid endarterectomy.
APPENDIX E1. Patient Complexity Components
Eighteen dichotomous comorbidity components were
chosen to characterize patient complexity as follows:
 Age>75 years
 Bodymass index>30 kg $m2 (obese) or<18.5 kg $m2
(underweight)
 Acuity: emergency, preoperative intra-aortic balloon
pump, cardiogenic shock, preoperativemechanical circu-
latory support, or inotrope support
 Previous myocardial infarction
 Reduced left ventricular function (ejection fraction
<50%)
 Arrhythmia: atrial or ventricular
 Heart failure: diagnosis within 2 weeks of surgery, parox-
ysmal nocturnal dyspnea, dyspnea on exertion, pulmo-
nary edema, or medications for heart failure
 Cardiac reoperation
 Pharmacologically treated diabetes mellitus: oral agents
or insulin
 Peripheral arterial disease
 Hypertension
 History of chronic obstructive pulmonary disease
 History of malignancy
 Renal failure: preoperative dialysis or creatinine>2.5
mg/dL
 Dyslipidemia: total cholesterol >200 mg/dL or low-
density lipoprotein130 or high-density lipoprotein<40
 Bilirubin>1.0 mg/dL
 Anemia: hematocrit<35%
 Cerebral vascular disease: stroke, transient ischemic
attack, carotid stenosis>75%, prior carotid surgery
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BOX E2. Mitral valve combinations with 5 operations performed
Isolated MV
MV + 1 component
+ CABG
+ AV
+ TV
+ AF
+ Aorta
+ Septal myectomy
+ ASD/PFO
MV + 2 components
+ Aorta + AV
+ Aorta + CABG
+ AV + AF
+ AV + CABG
+ AV + TV
+ CABG + AF
+ CABG + ASD/PFO
+ CEA + AF
+ TV + AF
+ TV + ASD/PFO
+ TV + CABG
+ Major LV procedure + CABG
+ Septal myectomy + AV
+ Septal myectomy + AF
MV + 3 components
+ Aorta + AV + CABG
+ Aorta + AV + TV
+ Aorta + AV + AF
+ AV + CABG + AF
+ AV + TV + AF
+ AV + TV + CABG
+ TV + CABG + AF
+ TV + CEA + AF
MV + 4 components
+ CABG + AV + TV + AF
+ Aorta + CABG + AV + TV
+ Aorta + CABG + AV + AF
+ Aorta + AV + TV + AF
MV, Mitral valve surgery; CABG, coronary artery bypass grafting; AV, aortic valve
surgery; TV, tricuspid valve surgery; AF, maze procedure (including non–cut-and-
sew maze); aorta, aortic root, ascending aorta, or arch replacement; ASD/PFO, atrial
septal defect or patent foramen ovale closure; CEA, carotid endarterectomy.
BOX E3. Aorta combinations with 5 operations performed
Isolated aorta
Aorta + 1 component
+ CABG
+ AV
+ MV
+ ASD/PFO
Aorta + 2 components
+ AV + CABG
+ AV + MV
+ AV + TV
+ MV + CABG
+ AV + AF
+ AV + ASD/PFO
Aorta + 3 components
+ AV + MV + CABG
+ AV + TV + CABG
+ AV + MV + TV
+ AV + MV + AF
+ AV + CABG + AF
+ AV + CABG + ASD/PFO
Aorta + 4 components
+ AV + MV + TV + CABG
+ AV + MV + CABG + AF
+ AV + MV + TV + AF
Aorta, Aortic root, ascending aorta, or arch replacement; CABG, coronary artery
bypass grafting; AV, aortic valve surgery;MV, Mitral valve surgery; ASD/PFO, atrial
septal defect or patent foramen ovale closure; TV, tricuspid valve surgery; AF, maze
procedure (including non–cut-and-sew maze).
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TABLE E1. Preoperative patient complexity risk model
Parameter Estimate ± SE P
Demography
Older age* 0.58  0.029 <.0001
Female 0.49  0.047 <.0001
Lower BSAy 1.4  0.32 <.0001
Acuity
NYHA class (vs I)
II 0.55  0.059 <.0001
III 0.15  0.062 .02
IV 0.18  0.057 .002
Emergency operation 1.6  0.064 <.0001
Preoperative MCS 3.3  0.11 <.0001
Cardiac comorbidity
Previous MI 0.16  0.043 .0003
Degree of LV dysfunction (vs none)
Mild 0.0088  0.060 .9
Moderate 0.39  0.061 <.0001
Severe 0.55  0.071 <.0001
Atrial fibrillation 0.14  0.062 <.0001
Complete heart block 0.40  0.093 <.0001
Number of cardiac operations (vs 1)
2 0.61  0.048 <.0001
3 0.87  0.089 <.0001
4 0.83  0.18 <.0001
Noncardiac comorbidity
Diabetes 0.19  0.056 .0004
Peripheral arterial disease 0.22  0.055 <.0001
Hypertension 0.11  0.050 .03
COPD 0.37  0.061 <.0001
Smoking 0.11  0.043 .01
Higher BUNz 0.74  0.054 <.0001
Lower cholesterolx 0.56  0.074 <.0001
Higher bilirubinz 0.39  0.041 <.0001
Lower hematocritz 0.53  0.17 .001
Stroke 0.15  0.066 .02
Experience
Earlier date of operationjj 0.055  0.017 .001
Intercept 6.2  0.71 <.0001
C ¼ 0.81. SE, Standard error; BSA, body surface area; NYHA, New York Heart Asso-
ciation;MCS, mechanical circulatory support;MI, myocardial infarction; LV, left ven-
tricular; COPD, chronic obstructive pulmonary disease; BUN, blood urea nitrogen.
*Exponential transformation, exp(age/50). yInverse squared transformation, 1/bsa2.
zLogarithmic transformation. xInverse transformation, 200/cholesterol. jjYears
from January, 1, 1967.
TABLE E2. Logistic model for hospital death incorporating surgical
components
Procedure Estimate ± SE P
Pericardiectomy 1.26  0.22 <.0001
Major LV procedure 1.11  0.11 <.0001
Atrial myxoma 0.88  0.33 .007
Carotid endarterectomy 0.88  0.11 <.0001
Septal myectomy 0.62  0.20 .002
Aorta 0.84  0.075 <.0001
AV 0.21  0.050 <.0001
MV 0.40  0.052 <.0001
CABG 0.31  0.052 <.0001
AF 0.26  0.17 .12
TV 0.14  0.082 .10
Transplant 0.003  0.15 .9
Transmyocardial revascularization 0.14  0.60 .8
Atrial septal defect or patent foramen ovale
closure
0.21  0.20 .3
Preoperative risk 0.97  0.016 <.0001
Intercept 0.59  0.075 <.0001
C¼ 0.82. SE, Standard error; LV, left ventricle; aorta, aortic root, ascending aorta, or
arch replacement; AV, aortic valve surgery;MV, mitral valve surgery;CABG, coronary
artery bypass grafting; AF, maze procedure (including non–cut-and-sew maze); TV,
tricuspid valve surgery.
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